Why the study?
What is the level and incidence of extrinsic contamination of lipid-formulated intravenous anaesthetics (propofol and etomidate) during clinical use?
What is the level and incidence of extrinsic contamination of lipid-formulated intravenous anaesthetics (propofol and etomidate) during clinical use?
The incidence of extrinsic contamination of lipid-formulated propofol and etomidate during clinical use is low, though strict aseptic precautions remain necessary.
Low contamination incidence may support routine use with aseptic technique; leaves open need for larger confirmatory studies.
Reports about post-operative infections associated with the use of propofol prompted us to investigate the in-use contamination of lipid-formulated intravenous (i.v.) anaesthetics used for general anaesthesia or for sedation of intensive care patients in this department. The level and incidence of extrinsic contamination of propofol ('Diprivan') and of another intravenous anaesthetic, etomidate, formulated in lipid solution ('Etomidat-lipuro') was found to be low during two study periods. However, the need to observe strict aseptic precautions in handling these intravenous drugs must be emphasized.
No takes yet. Share an insight, caveat, or question.
Bach et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: